XRTX XORTX Therapeutics Inc.

Nasdaq xortx.com


$ 0.59 $ -0.01 (-1.91 %)    

Monday, 10-Nov-2025 15:56:31 EST
QQQ $ 623.55 $ 4.78 (0.77 %)
DIA $ 473.74 $ 1.92 (0.41 %)
SPY $ 681.45 $ 4.27 (0.63 %)
TLT $ 89.54 $ 0.05 (0.06 %)
GLD $ 378.35 $ 2.41 (0.64 %)
$ 0.5581
$ 0.60
$ 0.58 x 100
$ 0.60 x 500
$ 0.58 - $ 0.60
$ 0.53 - $ 1.79
62,425
na
2.11M
$ 4.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

 xortx-therapeutics-issues-73871-shares-at-154-in-q1-2025-raising-net-proceeds-of-1097k-under-atm-program

Issuance of Shares under ATM OfferingIn other news, the Company confirms the issuance of 73,871 common shares at US$1.54 (CAD $...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION